-
Advancing Precision Therapy in Urothelial Carcinoma: A Collaborative Study by Professors Xuesong Li, Qi Tang, Jianhua Zhang, and Xiaoying Li Explores a Novel Approach to HER2 Assessment
A multidisciplinary team led by Professors Xuesong Li and Qi Tangfrom the Institute of Urology and Department of Urology, Peking University First Hospital, in collaboration with Professor Jianhua Zhang’s team from the Department of Nuclear Medicine and Professor Xiaoying Li’s team from the Department of Radiation Oncology, has published an original research article in Clinical…
-
Disitamab Vedotin–Based Combination Strategy Redefines First-Line Treatment for Advanced Urothelial Carcinoma, Nearly Doubling Overall Survival
In 2025, the 15th Shanghai Urologic Oncology Academic Conference was grandly held in Pudong, Shanghai. The meeting brought together leading experts in urologic oncology from China and around the world to engage in in-depth discussions on advances in the diagnosis and treatment of urothelial carcinoma, prostate cancer, renal cell carcinoma, and other major genitourinary malignancies.
-
2025 Tianjin International Breast Cancer Conference | Prof. Jihui Hao: A Blueprint for Intelligent Breast Cancer Prevention and Care
Editor’s Note From December 3 to 6, the Fifth Tianjin International Breast Cancer Conference was grandly held in Tianjin. The meeting was hosted by the Chinese Anti-Cancer Association and organized…
-
2025 Tianjin International Breast Cancer Conference | Prof. Zhongsheng Tong: Targeted Therapy Frontiers and the “Tianjin Experience”
Editor’s Note Recently, the 2025 Tianjin International Breast Cancer Conference, hosted by the Chinese Anti-Cancer Association and co-organized by Tianjin Medical University Cancer Institute and Hospital together with the National…
-
2025 Yat-sen Breast Cancer Conference | Prof. Qiang Liu: Advancing Multidisciplinary Care for Breast Cancer in China
Editor’s Note The 2025 Yat-sen Breast Cancer Conference, held in conjunction with the 2025 CSCO BC Southern Forum, the Second National Conference on the Release of the Chinese Expert Consensus…
-
2025 Yat-sen Breast Cancer Conference丨Professor Jing Yao: Addressing the Multiple Unique Needs of Young Breast Cancer Patients and Optimizing Treatment Choices Through Patient-Centered Care
The 2025 Yat-sen Breast Cancer Conference, held in conjunction with the 2025 CSCO BC Southern Forum, the Second National Conference on the Release of the Chinese Expert Consensus on the Diagnosis and Treatment of Young Breast Cancer, and the Fourth Yat-sen Breast Nursing Conference, took place in Guangzhou from December 26 to 27, 2025. The…
-
SABCS 2025 Insight Broadcast丨Professor Junjie Li: Exploring Precision Biomarkers for Neoadjuvant Therapy in HER2-Positive Breast Cancer
Spotlight on SABCS, insights delivered live. The 48th San Antonio Breast Cancer Symposium (SABCS) was held from December 9 to 12, 2025, in San Antonio, USA, bringing together cutting-edge research findings and clinical insights from across the global breast cancer community. To efficiently convey the highlights of the meeting, this edition of Insight Broadcast invited…
-
SABCS 2025 Insight Broadcast: Professor Jin Yang: Interpreting the New Landscape of First-Line Advanced and Early Adjuvant Therapy for HR+/HER2− Breast Cancer
Spotlight on SABCS, insights delivered in real time. The 48th San Antonio Breast Cancer Symposium (SABCS) was held from December 9 to 12, 2025, in San Antonio, USA, bringing together cutting-edge research findings and clinical insights from the global breast cancer community. To efficiently convey the key messages of the meeting, this edition of Insight…
Connecting Medical Expertise through Media